KNB Stock Overview
Kanabo Group Plc engages in the development and distribution of cannabis-derived solutions for medical and wellness products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Kanabo Group Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.018 |
| 52 Week High | UK£0.035 |
| 52 Week Low | UK£0.011 |
| Beta | 3.2 |
| 1 Month Change | -7.89% |
| 3 Month Change | -27.08% |
| 1 Year Change | -36.36% |
| 3 Year Change | -92.94% |
| 5 Year Change | n/a |
| Change since IPO | -95.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| KNB | GB Pharmaceuticals | GB Market | |
|---|---|---|---|
| 7D | -2.8% | 0.2% | -1.4% |
| 1Y | -36.4% | -5.3% | -2.4% |
Return vs Industry: KNB underperformed the UK Pharmaceuticals industry which returned -3.7% over the past year.
Return vs Market: KNB underperformed the UK Market which returned -1% over the past year.
Price Volatility
| KNB volatility | |
|---|---|
| KNB Average Weekly Movement | 11.2% |
| Pharmaceuticals Industry Average Movement | 8.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: KNB's share price has been volatile over the past 3 months.
Volatility Over Time: KNB's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 23 | Avihu Tamir | www.kanabogroup.com |
Kanabo Group Plc engages in the development and distribution of cannabis-derived solutions for medical and wellness products. It operates through Primary Care and Secondary Care segments. The company offers non- tetrahydrocannabinol products for cannabidiol consumers.
Kanabo Group Plc Fundamentals Summary
| KNB fundamental statistics | |
|---|---|
| Market cap | UK£11.07m |
| Earnings (TTM) | -UK£4.65m |
| Revenue (TTM) | UK£813.00k |
13.6x
P/S Ratio-2.4x
P/E RatioIs KNB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KNB income statement (TTM) | |
|---|---|
| Revenue | UK£813.00k |
| Cost of Revenue | UK£625.00k |
| Gross Profit | UK£188.00k |
| Other Expenses | UK£4.83m |
| Earnings | -UK£4.65m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0073 |
| Gross Margin | 23.12% |
| Net Profit Margin | -571.46% |
| Debt/Equity Ratio | 4.3% |
How did KNB perform over the long term?
See historical performance and comparison